Do analysts recommend ACON or PTHL?

Aclarion presently has a consensus target price of $7.50, suggesting a potential upside of 204.88%. Given Aclarion's stronger consensus rating and higher probable upside, analysts plainly believe Aclarion is more favorable than Pheton. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, ACON or PTHL?

Pheton has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $80K 88.56 -$7.23M -$7.40 N/A Pheton $305.22K 6.26 -$660K N/A N/A

Is ACON or PTHL more profitable?

Pheton has a net margin of 0.00% compared to Aclarion's net margin of -10,948.81%. Pheton's return on equity of 0.00% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion -10,948.81% -59.34% -56.12% Pheton N/A N/A N/A

Does the media prefer ACON or PTHL?

In the previous week, Aclarion had 2 more articles in the media than Pheton. MarketBeat recorded 3 mentions for Aclarion and 1 mentions for Pheton. Aclarion's average media sentiment score of 1.29 beat Pheton's score of 0.26 indicating that Aclarion is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aclarion 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pheton 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer ITOC or PTHL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, ITOC or PTHL?

Pheton has lower revenue, but higher earnings than Itonic. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Itonic $523.03K 10.21 -$5.10M N/A N/A Pheton $305.22K 6.26 -$660K N/A N/A

Is ITOC or PTHL more profitable?

Company Net Margins Return on Equity Return on Assets Itonic N/A N/A N/A Pheton N/A N/A N/A

Does the media refer more to ITOC or PTHL?

In the previous week, Itonic had 10 more articles in the media than Pheton. MarketBeat recorded 11 mentions for Itonic and 1 mentions for Pheton. Pheton's average media sentiment score of 0.26 beat Itonic's score of 0.07 indicating that Pheton is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Itonic 0 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Pheton 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate PTHL or HCTI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Healthcare Triangle 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, PTHL or HCTI?

Pheton has higher earnings, but lower revenue than Healthcare Triangle. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pheton $305.22K 6.26 -$660K N/A N/A Healthcare Triangle $13.89M 0.18 -$9.48M -$66.69 N/A

Does the media favor PTHL or HCTI?

In the previous week, Healthcare Triangle had 4 more articles in the media than Pheton. MarketBeat recorded 5 mentions for Healthcare Triangle and 1 mentions for Pheton. Healthcare Triangle's average media sentiment score of 1.48 beat Pheton's score of 0.26 indicating that Healthcare Triangle is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pheton 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Healthcare Triangle 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PTHL or VSEE?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, PTHL or VSEE?

Pheton has higher earnings, but lower revenue than VSee Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pheton $305.22K 6.26 -$660K N/A N/A VSee Health $14.46M 0.01 -$14.71M -$0.54 N/A

Is PTHL or VSEE more profitable?

Pheton has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Pheton's return on equity of 0.00% beat VSee Health's return on equity. Company Net Margins Return on Equity Return on Assets Pheton N/A N/A N/A VSee Health -92.36% -11,636.34% -68.62%

Do analysts recommend PTHL or MSPR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 MSP Recovery 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, PTHL or MSPR?

Pheton has higher earnings, but lower revenue than MSP Recovery. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pheton $305.22K 6.26 -$660K N/A N/A MSP Recovery $9.81M 0.00 -$360.50M -$572.83 N/A

Is PTHL or MSPR more profitable?

Pheton has a net margin of 0.00% compared to MSP Recovery's net margin of -7,328.48%. Pheton's return on equity of 0.00% beat MSP Recovery's return on equity. Company Net Margins Return on Equity Return on Assets Pheton N/A N/A N/A MSP Recovery -7,328.48% -326.80% -81.27%

Pheton (PTHL) Competitors

$0.29 -0.02 (-5.68%)

As of 08/13/2026

Compare

PTHL vs. ACON, ITOC, HCTI, VSEE, and MSPR

Should you buy Pheton stock or one of its competitors? Pheton's main competitors and comparable companies include Aclarion (ACON), Itonic (ITOC), Healthcare Triangle (HCTI), VSee Health (VSEE), and MSP Recovery (MSPR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Pheton compare to Aclarion?

Aclarion (NASDAQ:ACON) and Pheton (NASDAQ:PTHL) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

7.5% of Aclarion shares are held by institutional investors. 0.0% of Aclarion shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Aclarion had 2 more articles in the media than Pheton. MarketBeat recorded 3 mentions for Aclarion and 1 mentions for Pheton. Aclarion's average media sentiment score of 1.29 beat Pheton's score of 0.26 indicating that Aclarion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aclarion	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pheton	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aclarion presently has a consensus target price of $7.50, suggesting a potential upside of 204.88%. Given Aclarion's stronger consensus rating and higher probable upside, analysts plainly believe Aclarion is more favorable than Pheton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Aclarion has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market. Comparatively, Pheton has a beta of 5.4, suggesting that its share price is 440% more volatile than the broader market.

Pheton has a net margin of 0.00% compared to Aclarion's net margin of -10,948.81%. Pheton's return on equity of 0.00% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-10,948.81%	-59.34%	-56.12%
Pheton	N/A	N/A	N/A

Pheton has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$80K	88.56	-$7.23M	-$7.40	N/A
Pheton	$305.22K	6.26	-$660K	N/A	N/A

Summary

Aclarion beats Pheton on 8 of the 14 factors compared between the two stocks.

How does Pheton compare to Itonic?

Itonic (NASDAQ:ITOC) and Pheton (NASDAQ:PTHL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Itonic has a beta of 2.81, indicating that its share price is 181% more volatile than the broader market. Comparatively, Pheton has a beta of 5.4, indicating that its share price is 440% more volatile than the broader market.

In the previous week, Itonic had 10 more articles in the media than Pheton. MarketBeat recorded 11 mentions for Itonic and 1 mentions for Pheton. Pheton's average media sentiment score of 0.26 beat Itonic's score of 0.07 indicating that Pheton is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Itonic	0 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pheton	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pheton has lower revenue, but higher earnings than Itonic.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$523.03K	10.21	-$5.10M	N/A	N/A
Pheton	$305.22K	6.26	-$660K	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
Pheton	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Itonic and Pheton tied by winning 3 of the 6 factors compared between the two stocks.

How does Pheton compare to Healthcare Triangle?

Pheton (NASDAQ:PTHL) and Healthcare Triangle (NASDAQ:HCTI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

0.3% of Healthcare Triangle shares are held by institutional investors. 0.1% of Healthcare Triangle shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Pheton has a net margin of 0.00% compared to Healthcare Triangle's net margin of -66.84%. Pheton's return on equity of 0.00% beat Healthcare Triangle's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
Healthcare Triangle	-66.84%	-165.76%	-44.11%

Pheton has higher earnings, but lower revenue than Healthcare Triangle.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	6.26	-$660K	N/A	N/A
Healthcare Triangle	$13.89M	0.18	-$9.48M	-$66.69	N/A

In the previous week, Healthcare Triangle had 4 more articles in the media than Pheton. MarketBeat recorded 5 mentions for Healthcare Triangle and 1 mentions for Pheton. Healthcare Triangle's average media sentiment score of 1.48 beat Pheton's score of 0.26 indicating that Healthcare Triangle is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pheton	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Healthcare Triangle	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pheton has a beta of 5.4, suggesting that its stock price is 440% more volatile than the broader market. Comparatively, Healthcare Triangle has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Healthcare Triangle	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Pheton beats Healthcare Triangle on 6 of the 11 factors compared between the two stocks.

How does Pheton compare to VSee Health?

Pheton (NASDAQ:PTHL) and VSee Health (NASDAQ:VSEE) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Pheton has higher earnings, but lower revenue than VSee Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	6.26	-$660K	N/A	N/A
VSee Health	$14.46M	0.01	-$14.71M	-$0.54	N/A

Pheton has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Pheton's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
VSee Health	-92.36%	-11,636.34%	-68.62%

1.0% of VSee Health shares are held by institutional investors. 14.9% of VSee Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, VSee Health had 1 more articles in the media than Pheton. MarketBeat recorded 2 mentions for VSee Health and 1 mentions for Pheton. VSee Health's average media sentiment score of 0.44 beat Pheton's score of 0.26 indicating that VSee Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Pheton	Neutral
VSee Health	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Pheton and VSee Health tied by winning 5 of the 10 factors compared between the two stocks.

How does Pheton compare to MSP Recovery?

Pheton (NASDAQ:PTHL) and MSP Recovery (NASDAQ:MSPR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, Pheton had 1 more articles in the media than MSP Recovery. MarketBeat recorded 1 mentions for Pheton and 0 mentions for MSP Recovery. Pheton's average media sentiment score of 0.26 beat MSP Recovery's score of 0.00 indicating that Pheton is being referred to more favorably in the media.

Company	Overall Sentiment
Pheton	Neutral
MSP Recovery	Neutral

3.8% of MSP Recovery shares are held by institutional investors. 50.5% of MSP Recovery shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Pheton has a beta of 5.4, indicating that its share price is 440% more volatile than the broader market. Comparatively, MSP Recovery has a beta of -2.24, indicating that its share price is 324% less volatile than the broader market.

Pheton has higher earnings, but lower revenue than MSP Recovery.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	6.26	-$660K	N/A	N/A
MSP Recovery	$9.81M	0.00	-$360.50M	-$572.83	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
MSP Recovery	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Pheton has a net margin of 0.00% compared to MSP Recovery's net margin of -7,328.48%. Pheton's return on equity of 0.00% beat MSP Recovery's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
MSP Recovery	-7,328.48%	-326.80%	-81.27%

Summary

Pheton beats MSP Recovery on 8 of the 11 factors compared between the two stocks.

Get Pheton News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PTHL vs. The Competition

Export

Metric	Pheton	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.91M	$1.62B	$7.06B	$13.10B
Dividend Yield	N/A	4.69%	2.57%	10.45%
P/E Ratio	N/A	24.17	269.06	25.28
Price / Sales	6.26	72.88	592.57	87.62
Price / Cash	N/A	30.75	70.48	50.90
Price / Book	0.31	6.52	12.91	6.24
Net Income	-$660K	-$25.90M	$3.45B	$347.60M
7 Day Performance	0.24%	3.06%	1.12%	1.07%
1 Month Performance	-10.51%	5.27%	1.79%	1.03%
1 Year Performance	-56.45%	-15.58%	67.69%	20.77%

Pheton Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PTHL Pheton	N/A	$0.29 -5.7%	N/A	-52.6%	$1.91M	$305.22K	N/A	11	Gap Down
ACON Aclarion	3.1318 of 5 stars	$2.43 +1.1%	$7.50 +209.2%	-66.1%	$6.87M	$80K	N/A	7
ITOC Itonic	0.6706 of 5 stars	$0.33 +11.9%	N/A	N/A	$5.54M	$520K	N/A	N/A	News Coverage
HCTI Healthcare Triangle	0.9785 of 5 stars	$1.22 -29.2%	N/A	-99.1%	$2.48M	$13.89M	N/A	80	News Coverage Positive News Earnings Report Gap Down
VSEE VSee Health	0.1485 of 5 stars	$0.03 -6.2%	N/A	-96.6%	$98K	$14.46M	N/A	N/A	Short Interest Increase Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PTHL) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Pheton (PTHL) Competitors